Etonogestrel and ethinylestradiol vaginal delivery system product-specific bioequivalence
Table of contents
This document provides product-specific guidance on the demonstration of the etonogestrel and ethinylestradiol vaginal delivery system 0.12mg/0.015mg/day.
Keywords: Bioequivalence, etonogestrel, ethinylestradiol
Abbreviations
- BCSrmaceutics Classification System
- AUC0-t: area under the plasma concentration curve from administration to last observed concentration at time t
- Cmax: maximum plasma concentration